NVNO logo

EnVVeno Medical (NVNO) Cash From Investing

Annual CFI

-$7.87 M
+$26.69 M+77.23%

December 31, 2023

Summary

Performance

1-Year Change

+77.23%

3-Year Change

-4263.84%

5-Year Change

-63351.61%

15-Year Change

-4859.83%

NVNO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

32.8%
NVNO annual cash flow from investing activities is higher than 32.8% of companies in Healthcare sector

High & Low

All-time High

$165.30 K
NVNO annual cash flow from investing activities is currently -4859.83% below its historical high of $165.30 thousand

3-Year Low

-$34.55 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
NVNO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Feb 28, 2025
NVNO next annual earnings announcement is scheduled for Feb 28, 2025

OtherNVNOcash flowmetrics:

Annual CFF

$25.79 M
NVNO annual cash flow from financing activities is $25.79 million

Annual CFO

-$18.86 M
NVNO annual cash flow from operations is -$18.86 million

Annual FCF

-$18.89 M
NVNO annual free cash flow is -$18.89 million

Annual CAPEX

-
NVNO annual capital expenditures value is unknown

Quarterly CFI

$6.22 M
+$2.25 M+56.52%

September 30, 2024

Summary

Performance

3-Month Change

+56.52%

1-Year Change

+128.09%

3-Year Change

+120.02%

5-Year Change

+120.02%

NVNO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

80.98%
NVNO quarterly cash flow from investing activities is higher than 80.98% of companies in Healthcare sector

High & Low

All-time High

$7.00 M
NVNO quarterly cash flow from investing activities is currently -11.19% below its historical high of $7.00 million

3-Year Low

-$38.31 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NVNO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
NVNO next earnings announcement is scheduled for Feb 28, 2025

OtherNVNOcash flowmetrics:

Quarterly CFF

$13.59 M
NVNO quarterly cash flow from financing activities is $13.59 million

Quarterly CFO

-$4.28 M
NVNO quarterly cash flow from operations is -$4.28 million

Quarterly FCF

-$4.29 M
NVNO quarterly free cash flow is -$4.29 million

Quarterly CAPEX

-
NVNO quarterly capital expenditures value is unknown

TTM CFI

-$9.75 M
+$1.77 M+15.40%

September 30, 2024

Summary

Performance

3-Month Change

+15.4%

1-Year Change

-23.96%

3-Year Change

+69.19%

5-Year Change

+69.19%

NVNO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

33.21%
NVNO TTM cash flow from investing activities is higher than 33.21% of companies in Healthcare sector

High & Low

All-time High

$19.79 M
NVNO TTM cash flow from investing activities is currently -149.28% below its historical high of $19.79 million

3-Year Low

-$40.13 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
NVNO previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Feb 28, 2025
NVNO next earnings announcement is scheduled for Feb 28, 2025

OtherNVNOcash flowmetrics:

TTM CFF

$39.43 M
NVNO TTM cash flow from financing activities is $39.43 million

TTM CFO

-$16.71 M
NVNO TTM cash flow from operations is -$16.71 million

TTM FCF

-$16.74 M
NVNO TTM free cash flow is -$16.74 million

TTM CAPEX

-
NVNO TTM capital expenditures value is unknown

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

NVNO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+77.2%+128.1%-24.0%
3 y3 years-4263.8%+120.0%+69.2%
5 y5 years-10000.0%+120.0%+69.2%

NVNO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-2038.0%+77.2%-11.2%+116.2%-149.3%+75.7%
5 y5-year-4263.8%+77.2%-11.2%+116.2%-149.3%+75.7%
alltimeall time-4859.8%+77.2%-11.2%+116.2%-149.3%+75.7%

EnVVeno Medical Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
$6.22 M(+56.5%)
-$9.75 M(-15.4%)
Jun 2024
-
$3.97 M(+80.9%)
-$11.53 M(+35.7%)
Mar 2024
-
$2.20 M(-109.9%)
-$8.50 M(+8.0%)
Dec 2023
-$7.87 M(-77.2%)
-$22.14 M(-598.2%)
-$7.87 M(-139.8%)
Sep 2023
-
$4.45 M(-36.5%)
$19.79 M(+44.9%)
Jun 2023
-
$7.00 M(+147.8%)
$13.65 M(-143.1%)
Mar 2023
-
$2.83 M(-48.7%)
-$31.66 M(-8.4%)
Dec 2022
-$34.55 M(+9289.7%)
$5.52 M(-426.0%)
-$34.55 M(-13.9%)
Sep 2022
-
-$1.69 M(-95.6%)
-$40.13 M(+4.0%)
Jun 2022
-
-$38.31 M(>+9900.0%)
-$38.59 M(+9245.0%)
Mar 2022
-
-$69.00 K(+6.2%)
-$413.00 K(+12.2%)
Dec 2021
-$368.00 K(+104.1%)
-$65.00 K(-57.2%)
-$368.00 K(+11.3%)
Sep 2021
-
-$152.00 K(+19.7%)
-$330.50 K(+62.4%)
Jun 2021
-
-$127.00 K(+429.2%)
-$203.50 K(+2.3%)
Mar 2021
-
-$24.00 K(-12.7%)
-$199.00 K(+10.4%)
Dec 2020
-$180.30 K
-$27.50 K(+10.0%)
-$180.30 K(+8.7%)
DateAnnualQuarterlyTTM
Sep 2020
-
-$25.00 K(-79.6%)
-$165.80 K(-47.0%)
Jun 2020
-
-$122.50 K(+2211.3%)
-$312.70 K(-14.9%)
Mar 2020
-
-$5300.00(-59.2%)
-$367.40 K(+1.0%)
Dec 2019
-$363.90 K(+2834.7%)
-$13.00 K(-92.4%)
-$363.90 K(+2.5%)
Sep 2019
-
-$171.90 K(-3.0%)
-$355.00 K(+85.5%)
Jun 2019
-
-$177.20 K(+9744.4%)
-$191.40 K(+1247.9%)
Mar 2019
-
-$1800.00(-56.1%)
-$14.20 K(+14.5%)
Dec 2018
-$12.40 K(-107.5%)
-$4100.00(-50.6%)
-$12.40 K(-120.4%)
Sep 2018
-
-$8300.00(<-9900.0%)
$60.80 K(-68.4%)
Jun 2018
-
$0.00(0.0%)
$192.70 K(+149.9%)
Mar 2018
-
$0.00(-100.0%)
$77.10 K(-53.4%)
Dec 2017
$165.30 K(-144.3%)
$69.10 K(-44.1%)
$165.30 K(+71.8%)
Sep 2017
-
$123.60 K(-206.9%)
$96.20 K(-451.1%)
Jun 2017
-
-$115.60 K(-231.1%)
-$27.40 K(-131.1%)
Mar 2017
-
$88.20 K
$88.20 K
Dec 2016
-$372.80 K(+380.4%)
-
-
Dec 2015
-$77.60 K
-
-

FAQ

  • What is enVVeno Medical annual cash flow from investing activities?
  • What is the all time high annual CFI for enVVeno Medical?
  • What is enVVeno Medical annual CFI year-on-year change?
  • What is enVVeno Medical quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for enVVeno Medical?
  • What is enVVeno Medical quarterly CFI year-on-year change?
  • What is enVVeno Medical TTM cash flow from investing activities?
  • What is the all time high TTM CFI for enVVeno Medical?
  • What is enVVeno Medical TTM CFI year-on-year change?

What is enVVeno Medical annual cash flow from investing activities?

The current annual CFI of NVNO is -$7.87 M

What is the all time high annual CFI for enVVeno Medical?

enVVeno Medical all-time high annual cash flow from investing activities is $165.30 K

What is enVVeno Medical annual CFI year-on-year change?

Over the past year, NVNO annual cash flow from investing activities has changed by +$26.69 M (+77.23%)

What is enVVeno Medical quarterly cash flow from investing activities?

The current quarterly CFI of NVNO is $6.22 M

What is the all time high quarterly CFI for enVVeno Medical?

enVVeno Medical all-time high quarterly cash flow from investing activities is $7.00 M

What is enVVeno Medical quarterly CFI year-on-year change?

Over the past year, NVNO quarterly cash flow from investing activities has changed by +$28.36 M (+128.09%)

What is enVVeno Medical TTM cash flow from investing activities?

The current TTM CFI of NVNO is -$9.75 M

What is the all time high TTM CFI for enVVeno Medical?

enVVeno Medical all-time high TTM cash flow from investing activities is $19.79 M

What is enVVeno Medical TTM CFI year-on-year change?

Over the past year, NVNO TTM cash flow from investing activities has changed by -$1.89 M (-23.96%)